Note: This document contains side effect information about homatropine ophthalmic. Some of the dosage forms listed on this page may not apply to the brand name Homatropaire.
Applies to homatropine ophthalmic: ophthalmic solution
Side effects include:
Elevated IOP, transient stinging, burning. With prolonged administration, local irritation (characterized by follicular conjunctivitis, vascular congestion, edema, exudate, and eczematoid dermatitis ), thirst, dry mouth, increased light sensitivity of eyes.
Applies to homatropine ophthalmic: compounding powder, ophthalmic solution
The most frequently reported side effects were transient stinging/burning upon instillation and increased sensitivity to light.
Common (1% to 10%): Transient burning, transient stinging, increased sensitivity to light
Uncommon (0.1% to 1%): Eye irritation
Rare (0.01% to 0.1%): Local irritation, vascular congestion, edema, exudates, eczematoid dermatitis, follicular conjunctivitis
Postmarketing reports: Conjunctivitis, photophobia, mydriasis prolonged, eye pain, eye edema, eye discharge, eye irritation, ocular hyperemia
Rare (0.01% to 0.1%): Thirst, dryness of mouth
Frequency not reported: Abdominal distention infants, gastrointestinal motility diminished, salivary secretion decreased, sweat gland secretion decreased
Frequency not reported: Ataxia, incoherent speech, hyperactivity, seizure, unusual drowsiness
Postmarketing reports: Somnolence
Frequency not reported: Restlessness, hallucination, disorientation, failure to recognize people
Postmarketing reports: Confusion
Frequency not reported: Urinary retention
Frequency not reported: Secretion decreased in pharynx/bronchi/nasal passages, rapidly progressive respiratory depression
Frequency not reported: Hyperpyrexia
Frequency not reported: Tachycardia, vasodilation, hypotension
Postmarketing reports: Heart rate increased
Frequency not reported: Skin rash
Medically reviewed by BestRx Medical Team Last updated on 1/1/2020.
Source: Drugs.com Homatropaire